Global Kidney Academy

Enhance your nephrology practice with CME and tools focused on kidney medicine.

Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
CME/CE In-Person Event
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
June 05, 2026
Glasgow
1.00 credit
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits
MinuteCE®
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Leonie Kraft, MD
- Lucio Manenti, MD, PhD
- Emilio Sanchez, MD, PhD
1.00 credit 9 episodes
Is CKD-aP Hiding in Your Dialysis Center?
Is CKD-aP Hiding in Your Dialysis Center?
MinuteCE®
Is CKD-aP Hiding in Your Dialysis Center?
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit
CKD-aP or Something Else? Decoding the Diagnosis
CKD-aP or Something Else? Decoding the Diagnosis
MinuteCE®
CKD-aP or Something Else? Decoding the Diagnosis
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit
CKD-aP: Beyond the Surface
CKD-aP: Beyond the Surface
MinuteCE®
CKD-aP: Beyond the Surface
1.00 program credit
- Leonie Kraft, MD
1.00 program credit
Precision Medicine in IgAN: A Deep Dive into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
Precision Medicine in IgAN: A Deep Dive into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
IgAN
Precision Medicine in IgAN: A Deep Dive into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
- Chee Kay Cheung, MBChB, PhD, FRCP
- Raphael Duivenvoorden, MD, PhD
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
MinuteCE®
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
1.00 program credit
- James Burton, DM, FRCP
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit

Programs

Quantifying CKD-aP: Tools for Better Care 
Quantifying CKD-aP: Tools for Better Care 
MinuteCE®
Quantifying CKD-aP: Tools for Better Care 
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit
CKD-aP Treatment Tool Kit 
CKD-aP Treatment Tool Kit 
MinuteCE®
CKD-aP Treatment Tool Kit 
1.00 program credit
- Leonie Kraft, MD
- Emilio Sanchez, MD, PhD
1.00 program credit
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
MinuteCE®
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
1.00 program credit
- James Burton, DM, FRCP
- Patrick Rossignol, MD, PhD
1.00 program credit
MinuteCE®
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Javed Butler, MD
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 credit 9 episodes
Potassium Binders in Practice: Clinical Trial Evidence
Potassium Binders in Practice: Clinical Trial Evidence
MinuteCE®
Potassium Binders in Practice: Clinical Trial Evidence
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
The Critical Interplay: CKD, HF, and HyperkaleAmia
The Critical Interplay: CKD, HF, and HyperkaleAmia
MinuteCE®
The Critical Interplay: CKD, HF, and HyperkaleAmia
1.00 program credit
- James Burton, DM, FRCP
- Javed Butler, MD
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
MinuteCE®
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Javed Butler, MD, MPH, MBA
1.00 program credit
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
CME/CE
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
0.25 credits
- Jonathan Barratt, MD, PhD
- Sydney Tang, MBBS, MD
0.25 credits

CME

Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
- Nihar R. Desai, MD, MPH
0.25 credits
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
MinuteCE®
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
MinuteCE®
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
1.00 program credit
- James Burton, DM, FRCP
- Javed Butler, MD, MPH, MBA
1.00 program credit
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CE
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC
- Piotr Ponikowski, MD, PhD, FESC, FHFA
0.25 credits
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CE
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
- Thilo Krüger, MD, PhD
- Steven Fishbane, MD
- Lucio Manenti, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CE
KALMing the Itch: Improving QoL in Patients with CKD-aP
- Joel Topf, MD
- Kieran McCafferty, MD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CE
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
- Jonathan Barratt, MD, PhD
- Donald E. Kohan, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
Separating Fact from Fiction: The Realities of CKD-aP
CME/CE
Separating Fact from Fiction: The Realities of CKD-aP
- Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
- Antoine Lanot, MD, PhD

Global Kidney Academy

Popular

Programs

CME

Title

Welcome to Global Kidney Academy

Welcome to Global
Kidney Academy